Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Chubb
Federal Trade Commission
McKesson
Dow
Fish and Richardson
US Department of Justice
US Army

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018651

« Back to Dashboard

NDA 018651 describes MARINOL, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. Additional details are available on the MARINOL profile page.

The generic ingredient in MARINOL is dronabinol. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
Summary for 018651
Tradename:MARINOL
Applicant:Abbvie
Ingredient:dronabinol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018651
Ingredient-typeCannabinoids
Medical Subject Heading (MeSH) Categories for 018651
Suppliers and Packaging for NDA: 018651
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AbbVie Inc. 0051-0021 0051-0021-21 1 BOTTLE in 1 CARTON (0051-0021-21) > 60 CAPSULE in 1 BOTTLE
MARINOL dronabinol CAPSULE;ORAL 018651 NDA AbbVie Inc. 0051-0022 0051-0022-21 1 BOTTLE in 1 CARTON (0051-0022-21) > 60 CAPSULE in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:May 31, 1985TE:ABRLD:Yes

Expired US Patents for NDA 018651

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 ➤ Sign Up ➤ Sign Up
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 ➤ Sign Up ➤ Sign Up
Abbvie MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Chubb
Baxter
Moodys
Cerilliant
Medtronic
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.